CN105394773A - 用于改善便秘的复合益生菌和膳食纤维制剂 - Google Patents
用于改善便秘的复合益生菌和膳食纤维制剂 Download PDFInfo
- Publication number
- CN105394773A CN105394773A CN201510665792.9A CN201510665792A CN105394773A CN 105394773 A CN105394773 A CN 105394773A CN 201510665792 A CN201510665792 A CN 201510665792A CN 105394773 A CN105394773 A CN 105394773A
- Authority
- CN
- China
- Prior art keywords
- group
- preparation
- dietary fiber
- constipation
- lactobacillus acidophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010010774 Constipation Diseases 0.000 title claims abstract description 35
- 235000013325 dietary fiber Nutrition 0.000 title claims abstract description 35
- 239000006041 probiotic Substances 0.000 title claims abstract description 21
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 18
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 18
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 18
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 18
- 241000186012 Bifidobacterium breve Species 0.000 claims abstract description 16
- 241000220225 Malus Species 0.000 claims abstract description 4
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 4
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 4
- 230000000529 probiotic effect Effects 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 17
- 238000009472 formulation Methods 0.000 claims description 14
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 10
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 10
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 10
- 241000894006 Bacteria Species 0.000 abstract description 20
- 235000005911 diet Nutrition 0.000 abstract description 5
- 235000016709 nutrition Nutrition 0.000 abstract description 5
- 230000035764 nutrition Effects 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 241001247821 Ziziphus Species 0.000 abstract 2
- 208000002193 Pain Diseases 0.000 abstract 1
- 235000012041 food component Nutrition 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 30
- 239000000835 fiber Substances 0.000 description 25
- 210000001072 colon Anatomy 0.000 description 20
- 210000001519 tissue Anatomy 0.000 description 17
- 230000014509 gene expression Effects 0.000 description 12
- 230000037396 body weight Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 7
- 210000003384 transverse colon Anatomy 0.000 description 7
- 102000004363 Aquaporin 3 Human genes 0.000 description 6
- 108090000991 Aquaporin 3 Proteins 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000002158 endotoxin Substances 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 238000003935 denaturing gradient gel electrophoresis Methods 0.000 description 5
- 241000186660 Lactobacillus Species 0.000 description 4
- 230000000112 colonic effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102100027754 Mast/stem cell growth factor receptor Kit Human genes 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 3
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000007621 cluster analysis Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000005176 gastrointestinal motility Effects 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000009182 swimming Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 206010070545 Bacterial translocation Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102100021238 Dynamin-2 Human genes 0.000 description 1
- 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000007375 bacterial translocation Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- RDOIQAHITMMDAJ-UHFFFAOYSA-N loperamide Chemical compound C=1C=CC=CC=1C(C=1C=CC=CC=1)(C(=O)N(C)C)CCN(CC1)CCC1(O)C1=CC=C(Cl)C=C1 RDOIQAHITMMDAJ-UHFFFAOYSA-N 0.000 description 1
- 229960001571 loperamide Drugs 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
组别 | 内毒素含量(EU/mL) |
正常组 | 0.07±0.01b |
便秘组组 | 0.88±0.31a |
益生菌组 | 0.44±0.20ab |
苹果纤维组 | 0.71±0.31ab |
益生菌+苹果纤维组 | 0.21±0.18ab |
对照组 | 实验组 | P值 | |
GSH(mg/gprot) | 2.55±0.13 | 2.30±0.29 | >0.05 |
MAD(nmol/ml) | 6.37±0.24 | 6.56±0.09 | >0.05 |
△体重(g) | 36.03±6.11 | 48.61±5.20 | <0.05 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510665792.9A CN105394773B (zh) | 2015-10-16 | 2015-10-16 | 用于改善便秘的复合益生菌和膳食纤维制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510665792.9A CN105394773B (zh) | 2015-10-16 | 2015-10-16 | 用于改善便秘的复合益生菌和膳食纤维制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105394773A true CN105394773A (zh) | 2016-03-16 |
CN105394773B CN105394773B (zh) | 2018-12-28 |
Family
ID=55460819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510665792.9A Active CN105394773B (zh) | 2015-10-16 | 2015-10-16 | 用于改善便秘的复合益生菌和膳食纤维制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105394773B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108795823A (zh) * | 2018-07-04 | 2018-11-13 | 中科宜康(北京)生物科技有限公司 | 一种改善女性孕产妇肠道菌群的益生菌的培养方法和应用 |
CN113318168A (zh) * | 2021-06-08 | 2021-08-31 | 深圳市龙岗区妇幼保健院 | 一种改善顽固性便秘的组合物及其用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806368A (en) * | 1987-09-16 | 1989-02-21 | Reddy Malireddy S | Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation |
CN101744239A (zh) * | 2008-12-01 | 2010-06-23 | 青岛东海药业有限公司 | 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用 |
CN101897729A (zh) * | 2009-05-31 | 2010-12-01 | 金士力佳友(天津)有限公司 | 一种益生菌组合物及其制剂 |
CN104398538A (zh) * | 2014-10-28 | 2015-03-11 | 大连医科大学 | 一种用于减轻化疗副作用的复合益生菌制剂 |
-
2015
- 2015-10-16 CN CN201510665792.9A patent/CN105394773B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4806368A (en) * | 1987-09-16 | 1989-02-21 | Reddy Malireddy S | Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation |
CN101744239A (zh) * | 2008-12-01 | 2010-06-23 | 青岛东海药业有限公司 | 膳食纤维在制备防治便臭或便臭中毒综合征制剂中的应用 |
CN101897729A (zh) * | 2009-05-31 | 2010-12-01 | 金士力佳友(天津)有限公司 | 一种益生菌组合物及其制剂 |
CN104398538A (zh) * | 2014-10-28 | 2015-03-11 | 大连医科大学 | 一种用于减轻化疗副作用的复合益生菌制剂 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108795823A (zh) * | 2018-07-04 | 2018-11-13 | 中科宜康(北京)生物科技有限公司 | 一种改善女性孕产妇肠道菌群的益生菌的培养方法和应用 |
CN113318168A (zh) * | 2021-06-08 | 2021-08-31 | 深圳市龙岗区妇幼保健院 | 一种改善顽固性便秘的组合物及其用途 |
Also Published As
Publication number | Publication date |
---|---|
CN105394773B (zh) | 2018-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Anukam et al. | Probiotics: 100 years (1907–2007) after Elie Metchnikoff’s observation | |
CN110325198B (zh) | 益生菌在治疗和/或预防银屑病中的用途 | |
CN102711778B (zh) | 利用动物双歧杆菌细菌或含有这种细菌的发酵乳制品减轻胃肠炎症的方法 | |
JP5498698B2 (ja) | シロキクラゲ雑多糖またはその抽出物の新用途 | |
Farré-Maduell et al. | The origins of gut microbiome research in Europe: From Escherich to Nissle | |
US20180271919A1 (en) | Probiotic composition at least comprising bifidobacterium bifidum w23 and capable of controlling intestinal barrier function | |
CN108367033A (zh) | 使用长双歧杆菌治疗或预防抑郁症状的方法和组合物 | |
RU2704133C2 (ru) | Применение lactobacillus paracasei для усиления восстановления разнообразия кишечной микрофлоры после дисбактериоза | |
US11147843B2 (en) | Method of preventing or treating obesity using a novel strain of Parabacteroides goldsteinii | |
CN106659747A (zh) | 鼠李糖乳杆菌促进生态失调后肠道菌群多样性恢复的应用 | |
CN101998834B (zh) | 用于缓解胃肠道病症相关症状的益生菌 | |
CN101076346B (zh) | 乳酸菌及其在预防腹泻中的应用 | |
CN107206033A (zh) | 使用凝结芽孢杆菌sbc37‑01,mtcc 5856治疗性处理腹泻型肠易激综合征的方法 | |
Hickson | Examining the evidence for the use of probiotics in clinical practice | |
CN105394773A (zh) | 用于改善便秘的复合益生菌和膳食纤维制剂 | |
CN104398538A (zh) | 一种用于减轻化疗副作用的复合益生菌制剂 | |
CN103079581A (zh) | 用于改进跨上皮电阻的益生菌株 | |
US10953049B2 (en) | Methods for maintaining and improving kidney function in patients with kidney disease and on standard of care therapy | |
RU2546253C2 (ru) | Способ получения персонифицированного аутопробиотического продукта и способ лечения синдрома раздраженной кишки с использованием этого продукта | |
Kiran et al. | Specific probiotics for chronic kidney disease: A review | |
US20200281991A1 (en) | Methods and compositions for treating disorders related to a gut dysbiosis | |
Srinivasa et al. | A prospective study to evaluate the safety and efficacy of symbiotic supplementation (probiotic and prebiotic combination) in stage 5D chronic kidney disease patients | |
CN115895961B (zh) | 一种降血压的益生菌粉及其应用 | |
US20230042960A1 (en) | Microbial compositions and methods for treatment and detection of disease | |
Diana et al. | Microbiota and recurrent abdominal pain in children. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230809 Address after: 116000 floor 1, - 1, No. 61-10, Binhai West Road, Xigang District, Dalian City, Liaoning Province Patentee after: Liaoning Boao Jingdian Qiheng Yijia Bioengineering Co.,Ltd. Address before: 116044, No. nine, west section of Lushun South Road, Lushunkou District, Liaoning, Dalian Patentee before: DALIAN MEDICAL University |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 116011 1st and 1st floors, No. 61-10 Binhai West Road, Xigang District, Dalian City, Liaoning Province Patentee after: Boao Yijia (Liaoning) Biotechnology Co.,Ltd. Country or region after: China Address before: 116000 floor 1, - 1, No. 61-10, Binhai West Road, Xigang District, Dalian City, Liaoning Province Patentee before: Liaoning Boao Jingdian Qiheng Yijia Bioengineering Co.,Ltd. Country or region before: China |